Skip to Main Content

Paper Details

Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination.
Am J Transplant
14
2022
Author NameAffiliation
Andrew PekoszJohns Hopkins University Bloomberg School of Public Health
Aaron A R TobianThe Johns Hopkins University School of Medicine
  • 1 - 2

Datasets